Lung Carcinoma (NSCLC) Profile Test in Ahmedabad
50+ booked in last 3 daysOverview
The "Lung Carcinoma (NSCLC) Profile" is a comprehensive test used to evaluate specific markers and genetic alterations in non-small cell lung carcinoma (NSCLC). It involves the analysis of lung tissue obtained through a tru-cut biopsy and includes the following components: Reflex Immunohistochemistry (IHC): Immunohistochemistry is a technique that uses antibodies to detect specific proteins in tumor tissue. In this profile, reflex IHC is used to assess the presence of two critical biomarkers: EGFR & ALK. EGFR (Epidermal Growth Factor Receptor) Mutation Detection: The test specifically detects mutations in two common EGFR exons - Exon 19 deletion and Exon 21 L858R. EGFR mutations are important molecular markers in NSCLC and can guide treatment decisions, as certain targeted therapies are available for patients with EGFR-mutated tumors. ALK (Anaplastic Lymphoma Kinase) IHC: ALK rearrangements are another genetic alteration found in a subset of NSCLC patients. ALK IHC is used as a screening tool to identify tumors with ALK rearrangements, and if positive, further confirmatory tests are conducted. The results of this profile provide valuable information to guide personalized treatment strategies for patients with NSCLC. Based on the detected biomarkers, targeted therapies can be considered to improve treatment outcomes and potentially avoid unnecessary exposure to ineffective treatments. Additionally, the profile aids in disease prognosis and monitoring to assess treatment response over time.
Lung Carcinoma (NSCLC) Profile Test Price in Ahmedabad
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Lung Carcinoma (NSCLC) Profile Test with a clear pricing structure
The price of Lung Carcinoma (NSCLC) Profile Test in Ahmedabad is ₹ 13,110
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Identifying lung tumors that may respond to targeted therapies by simultaneously assessing multiple genes involved in rearrangements.
Your doctor may suggest to Identify lung tumors that may respond to targeted therapies.
Targeted cancer therapies are defined as antibody or small molecule drugs that block the growth and spread of cancer by interfering with specific cell molecules involved in tumor growth and progression. Multiple targeted therapies have been approved by the FDA for treatment of specific cancers. Molecular genetic profiling is often needed to identify targets amenable to targeted therapies and to minimize treatment costs and therapy-associated risks.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.